쿼드메디슨
4,490KRWMarket close of 10/20 (Tue)
Up +4.66%+200KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)4,400KRWDown -2.00%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 4,290
- High
- 4,710
- Low
- 4,200
- Day range
- Day range low 4,200 high 4,710, open 4,290, close 4,490, previous close 4,290
- Volume
- 7×10K shares
- 298.30 million KRW 1.23× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
2%2% of the way up from the lowest close in 1 year (205 sessions) · -81.7% from the high
Usual range
Nothing unusual in the 3 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move+4.66%usual range
- Trading value1.2×usual range
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q2 2026
- Operating income-2.4B KRW
- vs. year ago
- Turned to loss
- vs. prior quarter
- Still a loss
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-08-13Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 26 days
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.